Silentium Ltd.

F-1/A amended

Price $7.00 · Range $6.00 to $8.00 · 2,150,000 shares · Gross proceeds $15,050,000

F-1/A amended

Range $6.00 to $8.00 · 2,150,000 shares

FWP supplemental

Range $6.00 to $8.00 · 2,150,000 shares

Silentium Ltd. is conducting an IPO with 2,150,000 ordinary shares offered at $6.00-$8.00 per share, expected to raise $15.05M. The company focuses on active acoustics technology for automotive and transportation sectors, with a scalable software-based solution. Revenue grew to $19.18M from 2021-2025, though historical financials for 2021-2023 lacked PCAOB audits. The offering aims to fund expansion, R&D, and OEM partnerships, with a pending NYSE American listing.

F-1/A amended

Range $6.00 to $8.00 · 2,150,000 shares

Silentium Ltd's F-1/A filing outlines its IPO details, including estimated net proceeds of $12.5 million (up to $14.7 million with underwriter options) from selling 2,150,000 ordinary shares at $7.00 each. Proceeds will fund OEM customer acquisition, R&D, expansion of existing business, partnerships, adjacent market entry, and working capital. The filing highlights capitalization changes, dilution risks for new investors, and forward-looking statements about market growth and operational plans. The company emphasizes its proprietary IP and market position in active acoustic management systems.

F-1 filed

Price $7.00 · Range $6.00 to $8.00 · 2,150,000 shares · Gross proceeds $17,200,000

Silentium Ltd. is conducting an IPO with an estimated net proceeds of $12.5 million, allocated to acquiring OEM customers, R&D, expanding existing customer relationships, strengthening partnerships, entering adjacent markets, and general corporate purposes. The filing includes detailed capitalization tables, pro forma adjustments for share conversions, and dilution analysis. The company emphasizes flexibility in fund usage and highlights risks related to product development and market demand.

DRS/A amended

DRS/A amended

Silentium Ltd. is preparing for its initial public offering (IPO) with detailed disclosures on Israeli corporate law requirements, share capital adjustments, and restrictions on share sales. The filing outlines legal frameworks for mergers, tender offers, and share acquisitions, emphasizing compliance with Israeli Companies Law. It also addresses post-IPO share liquidity, including lock-up agreements, registration rights, and potential market impacts from restricted share sales. Tax considerations, particularly contrasting Israeli and U.S. treatment of acquisitions, are highlighted as critical factors for investors.

DRS filed

Silentium Ltd.'s current DRS filing outlines key corporate governance requirements under Israeli law, including merger timelines, tender offer regulations, and share capital adjustments. The filing details restrictions on share sales, lock-up agreements for insiders, and registration rights for shareholders. Tax considerations highlight potential disadvantages for Israeli shareholders compared to U.S. tax treatments, particularly in stock-for-stock exchanges. The document also addresses eligibility for future share sales under Rule 144 and Rule 701, along with underwriter-related provisions.